New Zealand’s Fonterra on Wednesday agreed to sell its 50% stake in DFE Pharma for NZ$633 million ($400.37 million) as the world’s biggest dairy exporter trims its overseas portfolio to focus on domestic business.
Start your deal-making journey now!
Subscribe now to enjoy unlimited access at just $59.
Premium coverage on private equity, venture capital, and startups in Asia.
Exclusive scoops from our reporters in nine key markets.
In-depth interviews with industry leaders shaping the ecosystem.
Already a Subscriber? Log in
Contact us for corporate subscriptions at subs@dealstreetasia.com
